- Home
- RCKT vs EVCM Comparison
RCKT vs EVCM Comparison
Compare RCKT & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- EVCM
- Stock Information
- Founded
- RCKT 1999
- EVCM 2006
- Country
- RCKT United States
- EVCM United States
- Employees
- RCKT N/A
- EVCM N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- EVCM EDP Services
- Sector
- RCKT Health Care
- EVCM Technology
- Exchange
- RCKT Nasdaq
- EVCM Nasdaq
- Market Cap
- RCKT 264.0M
- EVCM 1.7B
- IPO Year
- RCKT N/A
- EVCM 2021
- Fundamental
- Price
- RCKT $2.99
- EVCM $10.65
- Analyst Decision
- RCKT Buy
- EVCM Buy
- Analyst Count
- RCKT 13
- EVCM 12
- Target Price
- RCKT $18.50
- EVCM $11.67
- AVG Volume (30 Days)
- RCKT 3.8M
- EVCM 255.6K
- Earning Date
- RCKT 08-04-2025
- EVCM 08-05-2025
- Dividend Yield
- RCKT N/A
- EVCM N/A
- EPS Growth
- RCKT N/A
- EVCM N/A
- EPS
- RCKT N/A
- EVCM N/A
- Revenue
- RCKT N/A
- EVCM $703,186,000.00
- Revenue This Year
- RCKT N/A
- EVCM N/A
- Revenue Next Year
- RCKT N/A
- EVCM $6.31
- P/E Ratio
- RCKT N/A
- EVCM N/A
- Revenue Growth
- RCKT N/A
- EVCM 7.84
- 52 Week Low
- RCKT $2.19
- EVCM $8.10
- 52 Week High
- RCKT $26.98
- EVCM $12.35
- Technical
- Relative Strength Index (RSI)
- RCKT 45.55
- EVCM 58.09
- Support Level
- RCKT $2.76
- EVCM $10.53
- Resistance Level
- RCKT $3.24
- EVCM $10.88
- Average True Range (ATR)
- RCKT 0.19
- EVCM 0.30
- MACD
- RCKT 0.17
- EVCM 0.06
- Stochastic Oscillator
- RCKT 74.85
- EVCM 79.67
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.